Unichem Laboratories Limited (NSE:UNICHEMLAB)
529.00
-58.00 (-9.88%)
Jul 22, 2026, 3:30 PM IST
Unichem Laboratories Revenue
In the fiscal year ending March 31, 2026, Unichem Laboratories had annual revenue of 22.02B INR with 4.31% growth. Unichem Laboratories had revenue of 5.75B in the quarter ending March 31, 2026, a decrease of -2.05%.
Revenue
22.02B
Revenue Growth
+4.31%
P/S Ratio
1.87
Revenue / Employee
7.92M
Employees
2,780
Market Cap
41.25B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 22.02B | 908.80M | 4.31% |
| Mar 31, 2025 | 21.11B | 3.26B | 18.25% |
| Mar 31, 2024 | 17.85B | 4.42B | 32.92% |
| Mar 31, 2023 | 13.43B | 731.90M | 5.76% |
| Mar 31, 2022 | 12.70B | 346.97M | 2.81% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Indoco Remedies | 18.45B |
| Aarti Pharmalabs | 18.19B |
| Innova Captab | 16.30B |
| Solara Active Pharma Sciences | 13.69B |
| Windlas Biotech | 9.04B |
| Orchid Pharma | 8.11B |
| RPG Life Sciences | 7.08B |
| Ind-Swift Laboratories | 6.41B |
Unichem Laboratories News
- 16 days ago - Unichem Laboratories schedules 63rd AGM for 11th August 2026 via virtual means - Business Upturn
- 7 weeks ago - Unichem Laboratories initiates transfer of unclaimed shares to IEPF - Business Upturn
- 2 months ago - Unichem Laboratories shares fall over 3% after weak Q4 results; Profit drops 79% YoY - Business Upturn
- 2 months ago - Unichem Laboratories Q4 Results: Net profit falls 79% YoY to Rs 10.9 crore, revenue declines 2% - Business Upturn
- 10 months ago - Unichem Laboratories shares fall 3% after €19.49 million EU penalty demand in perindopril case - Business Upturn
- 11 months ago - Unichem Pharmaceuticals recalls mislabeled Cyclobenzaprine tablets in US over safety concerns - Business Upturn
- 11 months ago - Unichem Laboratories’ Roha API facility gets VAI classification from USFDA - Business Upturn
- 1 year ago - Unichem Laboratories shares drop 4% after USFDA flags 3 procedural issues at Roha facility - Business Upturn